CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 58.2 USD 0.19%
Market Cap: 5.5B USD

Intrinsic Value

The intrinsic value of one CRSP stock under the Base Case scenario is hidden USD. Compared to the current market price of 58.2 USD, CRISPR Therapeutics AG is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CRSP Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
CRISPR Therapeutics AG

Intrinsic Value History
Dive into the past to invest in the future

CRSP looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CRSP usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CRSP?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CRSP valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CRISPR Therapeutics AG.

Explain Valuation
Compare CRSP to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CRSP?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CRISPR Therapeutics AG

Current Assets 1.9B
Cash & Short-Term Investments 1.9B
Other Current Assets 13.4m
Non-Current Assets 316.2m
Long-Term Investments 28.4m
PP&E 255.5m
Other Non-Current Assets 32.3m
Current Liabilities 119m
Accounts Payable 11.8m
Accrued Liabilities 102.4m
Other Current Liabilities 4.7m
Non-Current Liabilities 210.4m
Other Non-Current Liabilities 210.4m
Efficiency

Free Cash Flow Analysis
CRISPR Therapeutics AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CRISPR Therapeutics AG

Revenue
38.3m USD
Operating Expenses
-516.5m USD
Operating Income
-478.1m USD
Other Expenses
-10.2m USD
Net Income
-488.3m USD
Fundamental Scores

CRSP Profitability Score
Profitability Due Diligence

CRISPR Therapeutics AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

CRISPR Therapeutics AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CRSP Solvency Score
Solvency Due Diligence

CRISPR Therapeutics AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

CRISPR Therapeutics AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CRSP Price Targets Summary
CRISPR Therapeutics AG

Wall Street analysts forecast CRSP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRSP is 80 USD with a low forecast of 32.32 USD and a high forecast of 281.4 USD.

Lowest
Price Target
32.32 USD
44% Downside
Average
Price Target
80 USD
37% Upside
Highest
Price Target
281.4 USD
384% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

CRISPR Therapeutics AG
does not pay dividends
Shareholder Yield

Current shareholder yield for CRSP is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CRSP Insider Trading
Buy and sell transactions by insiders

CRSP News

Other Videos
What is the Intrinsic Value of one CRSP stock?

The intrinsic value of one CRSP stock under the Base Case scenario is hidden USD.

Is CRSP stock undervalued or overvalued?

Compared to the current market price of 58.2 USD, CRISPR Therapeutics AG is hidden .

Back to Top